Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PH-15 by VistaGen Therapeutics for Cognitive Impairment: Likelihood of Approval
PH-15 is under clinical development by VistaGen Therapeutics and currently in Phase II for Cognitive Impairment. According to GlobalData, Phase...